For the Inventor, By the Inventor

Enter inventor name

Encinitas, CA, United States of America

Alexandre Vasilievich Ivachtchenko

USPTO Granted Patents = 18 (Patent Applications = 17)

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 61(Granted Patents)

Location History:

Encinitas, CA (US) (2013 - 2017)
Hallandale, FL (US) (2019 - 2023)
Hallandale Beach, FL (US) (2020 - 2023)

Company Filing History:

Eil Therapeutics, Inc.

R-pharm Joint Stock Company (r-pharm, Jsc)

5. 14 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357619 - Noradrenergic and specific serotonergic anxiolytic and antidepressant, method for the production and use thereof (2025-07-15),

2. 11834450 - Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors (2023-12-05),

3. 11697650 - Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors (2023-07-11),

4. 11648300 - Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19 (2023-05-16),

5. 10738049 - N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-D]pyrimidin-1-YL]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate as an MEK1/2 inhibitor (2020-08-11),

6. 10683315 - Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereof (2020-06-16),

7. 10266558 - Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof (2019-04-23),

8. 9790207 - Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods (2017-10-17),

9. 9655886 - Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for use thereof (2017-05-23),

10. 9428491 - Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof (2016-08-30),

11. 9381201 - Pharmaceutical composition and kit for treating bacterial infections (2016-07-05),

12. 9370576 - Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same (2016-06-21),

13. 9085539 - Cyclic N,N'-diarylthiourea—androgen receptor antagonist, anti breast cancer composition and use thereof (2015-07-21),

14. 9073874 - Cyclic N,N'-diarylthioureas and N,N′-diarylureas-androgen receptor antagonists, anticancer agent, method for preparation and use thereof (2015-07-07),

15. 8895613 - Fluorosubstituted-(3R,4R,5S)-5-guanidino 4-acetamido-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid compound, ester and use thereof (2014-11-25),

Title: Innovations and Contributions of Inventor Alexandre Vasilievich Ivachtchenko

Introduction

Alexandre Vasilievich Ivachtchenko, based in Encinitas, CA, is a prominent inventor holding an impressive portfolio of 18 patents. His innovative contributions predominantly lie in the fields of pharmacology and mental health treatments, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest inventions is a novel Noradrenergic and Specific Serotonergic Anxiolytic and Antidepressant (NaSSA). This invention presents a method for the production and use of 2,8-dimethyl-5-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride, aimed at treating mental disorders in humans. Additionally, he has developed compounds serving as inhibitors of BCL-2 proteins, which are useful in addressing various diseases and disorders modulated by this enzyme.

Career Highlights

Ivachtchenko has made significant strides in the healthcare sector through his innovative work. His patents reflect a deep understanding of chemical compounds and their applications in therapeutic solutions, particularly for mental health. His contributions have the potential to enhance treatment options available for various mental health conditions.

Collaborations

Throughout his career, Ivachtchenko has collaborated with notable individuals in the field, including Oleg Dmitrievich Mitkin and Andrey Alexandrovich Ivashchenko. These partnerships have played a vital role in the development and refinement of his inventions, facilitating the translation of research into practical applications.

Conclusion

Alexandre Vasilievich Ivachtchenko is a dedicated inventor whose innovative work is poised to make a significant impact on the treatment of mental disorders. With his extensive patent portfolio and collaborative efforts, he continues to push the boundaries of pharmacological research, paving the way for new therapies that address pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…